Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14766)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 7, 2020 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Polidoro MA, Mikulak J, Cazzetta V, Lleo A, Mavilio D, Torzilli G, Donadon M. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. World J Gastroenterol 2020; 26(33): 4900-4918 [PMID: 32952338 DOI: 10.3748/wjg.v26.i33.4900] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i33/4900.htm |
| Number | Citing Articles |
| 1 |
Xiulin Xiao, Lin Zhou, Long Zhang, Zhiyuan Xu, Qixin Dai, Xiaohong Deng, Weiguo Li. Short-Term and Long-Term Curative Effect of Partial Hepatectomy on Ruptured Hemorrhage of Primary Liver Cancer after TAE. Emergency Medicine International 2022; 2022: 1 doi: 10.1155/2022/2484418
|
| 2 |
Massimiliano Cadamuro, Rocio I.R. Macias, Alastair J. Strain, Mario Strazzabosco, Paolo Simioni, Jose J.G. Marin, Luca Fabris. Unmet needs in basic and translational research in Cholangiocarcinoma. Liver Cancer International 2022; 3(1): 5 doi: 10.1002/lci2.39
|
| 3 |
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi, Massoud Vosough. Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future. European Journal of Cell Biology 2023; 102(1): 151284 doi: 10.1016/j.ejcb.2022.151284
|
| 4 |
Chengwen He, Qin Wei, Jun Zhu, Qin Qin, Huaizhou Wang, Shanrong Liu. Clinical value of assessing serum levels of inflammatory cytokines in the early diagnosis of patients with primary liver carcinoma: a retrospective observational study. Journal of Bio-X Research 2021; 4(01): 29 doi: 10.1097/JBR.0000000000000084
|
| 5 |
Valentina Cazzetta, Sara Franzese, Claudia Carenza, Silvia Della Bella, Joanna Mikulak, Domenico Mavilio. Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy. Cancers 2021; 13(9): 2184 doi: 10.3390/cancers13092184
|
| 6 |
Ruyin Chen, Qiong Li, Shuaishuai Xu, Chanqi Ye, Tian Tian, Qi Jiang, Jianzhen Shan, Jian Ruan. Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-021-02435-4
|
| 7 |
Devaraj Ezhilarasan, Mustapha Najimi. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver. Critical Reviews in Oncology/Hematology 2023; 182: 103902 doi: 10.1016/j.critrevonc.2022.103902
|
| 8 |
Sara Piccinelli, Rizwan Romee, Roman M. Shapiro. The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors. Seminars in Hematology 2023; 60(1): 42 doi: 10.1053/j.seminhematol.2023.02.002
|
| 9 |
Matteo Donadon, Marcello Di Martino, Paolo Baroffio, Michela Anna Polidoro. Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.14
|
| 10 |
Jannarong Intakhad, Arpamas Vachiraarunwong, Rawiwan Wongpoomchai, Chalermchai Pilapong. Ferric‐Tannic Nanoparticles Inhibit Early‐Stage Hepatocarcinogenesis by Activating Tumor Immune Responses in Rats. Advanced Therapeutics 2024; doi: 10.1002/adtp.202400348
|
| 11 |
Dashuai Yang, Yu Zhou, Yanbing Zhang, Yang Su, Jie Shen, Bin Yu, Kailiang Zhao, Youming Ding. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic model. Cancer Immunology, Immunotherapy 2023; 72(12): 4323 doi: 10.1007/s00262-023-03567-4
|
| 12 |
Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven S. Raman, Anahid Jewett, Jason Chiang.
Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma
. Critical Reviews in Immunology 2024; 44(5): 71 doi: 10.1615/CritRevImmunol.2024052486
|
| 13 |
Piyush Gondaliya, Adil Ali Sayyed, Julia Driscoll, Krishna Patel, Tushar Patel. Extracellular vesicle RNA signaling in the liver tumor microenvironment. Cancer Letters 2023; 558: 216089 doi: 10.1016/j.canlet.2023.216089
|
| 14 |
Francesca Vita, Irene Olaizola, Francesco Amato, Colin Rae, Sergi Marco, Jesus M. Banales, Chiara Braconi. Heterogeneity of Cholangiocarcinoma Immune Biology. Cells 2023; 12(6): 846 doi: 10.3390/cells12060846
|
| 15 |
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, Shalini Gautam, Disha Marwaha, Madhu Sharma, Prabhat Ranjan Mishra. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy. Journal of Controlled Release 2023; 363: 290 doi: 10.1016/j.jconrel.2023.09.016
|
| 16 |
Qijie Zhao, Rawiwan Wongpoomchai, Arpamas Chariyakornkul, Zhangang Xiao, Chalermchai Pilapong. Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740484
|
| 17 |
Guangsheng Zhao, Mei Bi, Song Liu, Jian Ma, Fang Xu, Ying Liu, Fei Gao, Ying Yu, Jun Zhou, Zhuo Feng, Jianlin Wu. Variation of NK, NKT, CD4+ T, CD8+ T cells, and IL-17A by CalliSpheres® microspheres-transarterial chemoembolization in refractory liver metastases patients. Scandinavian Journal of Clinical and Laboratory Investigation 2022; 82(7-8): 549 doi: 10.1080/00365513.2022.2129438
|
| 18 |
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 2022; 86: 799 doi: 10.1016/j.semcancer.2022.01.005
|
| 19 |
Haipeng Zhu, Xiaojun Liu. Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.666340
|
| 20 |
Neda Dadgar, Arun K. Arunachalam, Hanna Hong, Yee Peng Phoon, Jorge E. Arpi-Palacios, Melis Uysal, Chase J. Wehrle, Federico Aucejo, Wen Wee Ma, Jan Joseph Melenhorst. Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy. Cancers 2024; 16(18): 3232 doi: 10.3390/cancers16183232
|
| 21 |
Hongmin Han, Ziyin Zhao, Mingyang He, Ge Guan, Junning Cao, Tianxiang Li, Bing Han, Bin Zhang. Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1474869
|
| 22 |
Adriana G. Quiroz Reyes, Sonia A. Lozano Sepulveda, Natalia Martinez-Acuña, Jose F. Islas, Paulina Delgado Gonzalez, Tania Guadalupe Heredia Torres, Jorge Roacho Perez, Elsa N. Garza Treviño. Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231163677
|
| 23 |
Yinghui Zhu, Dezhi Shan, Lianyi Guo, Shujia Chen, Xiaofei Li. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma. International Journal of General Medicine 2022; : 1919 doi: 10.2147/IJGM.S343350
|